When it comes to amitriptyline, desvenlafaxine, duloxetine, escitalopram, paroxetine, toludesvenlafaxine, trazodone, and venlafaxine the risks of somnolence gradually increased from low doses to moderate doses and then showed a decreasing trend through the high doses.
← all excerpts
Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis.
1
—
—